Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+10.31%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$80.1B
AUM Growth
-$274M
Cap. Flow
-$5.85B
Cap. Flow %
-7.3%
Top 10 Hldgs %
12.21%
Holding
3,960
New
703
Increased
982
Reduced
1,701
Closed
552

Top Buys

1
AMZN icon
Amazon
AMZN
+$842M
2
NVDA icon
NVIDIA
NVDA
+$559M
3
MSFT icon
Microsoft
MSFT
+$420M
4
AAPL icon
Apple
AAPL
+$389M
5
MRNA icon
Moderna
MRNA
+$365M

Sector Composition

1 Healthcare 19.94%
2 Technology 19.65%
3 Consumer Staples 10.63%
4 Consumer Discretionary 10.51%
5 Communication Services 8.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CIH
3301
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$155K ﹤0.01%
77,199
-42,901
-36% -$86.1K
LIXT icon
3302
Lixte Biotechnology
LIXT
$24M
$154K ﹤0.01%
+5,090
New +$154K
TLSA icon
3303
Tiziana Life Sciences
TLSA
$209M
$153K ﹤0.01%
65,340
+17,193
+36% +$40.3K
TTSH icon
3304
Tile Shop Holdings
TTSH
$282M
$149K ﹤0.01%
+18,500
New +$149K
XTLB
3305
XTL Biopharmaceuticals
XTLB
$12.3M
$148K ﹤0.01%
37,187
-1,613
-4% -$6.42K
CXDO icon
3306
Crexendo
CXDO
$207M
$148K ﹤0.01%
24,267
+11,267
+87% +$68.7K
EMX
3307
EMX Royalty
EMX
$456M
$148K ﹤0.01%
+49,824
New +$148K
FENC icon
3308
Fennec Pharmaceuticals
FENC
$251M
$148K ﹤0.01%
+20,284
New +$148K
APM icon
3309
Aptorum Group
APM
$13.2M
$146K ﹤0.01%
+4,570
New +$146K
ENFY
3310
Enlightify Inc.
ENFY
$16.4M
$146K ﹤0.01%
14,751
-34,477
-70% -$341K
TMBR
3311
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$145K ﹤0.01%
+2,376
New +$145K
BDR
3312
DELISTED
Blonder Tongue Laboratories Inc
BDR
$143K ﹤0.01%
108,162
+26,800
+33% +$35.4K
ENTO
3313
Entero Therapeutics
ENTO
$3.65M
$142K ﹤0.01%
+1
New +$142K
TAOP icon
3314
Taoping
TAOP
$4.73M
$141K ﹤0.01%
+97
New +$141K
DSWL icon
3315
Deswell Industries
DSWL
$66.4M
$140K ﹤0.01%
29,385
+11,716
+66% +$55.8K
CMPI
3316
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$140K ﹤0.01%
+23,500
New +$140K
KRKR
3317
36Kr Holdings
KRKR
$16.2M
$139K ﹤0.01%
2,805
+250
+10% +$12.4K
QVCGB
3318
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$138K ﹤0.01%
+208
New +$138K
DARE icon
3319
Dare Bioscience
DARE
$28.4M
$137K ﹤0.01%
6,049
-66,652
-92% -$1.51M
RDHL
3320
Redhill Biopharma
RDHL
$3.67M
$137K ﹤0.01%
+20
New +$137K
DBTX
3321
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$137K ﹤0.01%
+15,900
New +$137K
LFMD icon
3322
LifeMD
LFMD
$279M
$134K ﹤0.01%
+11,400
New +$134K
CWBR
3323
DELISTED
CohBar, Inc. Common Stock
CWBR
$134K ﹤0.01%
3,200
-14,950
-82% -$626K
NH
3324
DELISTED
NantHealth, Inc
NH
$134K ﹤0.01%
+3,862
New +$134K
ZGYH
3325
DELISTED
Yunhong International Class A Ordinary Shares
ZGYH
$134K ﹤0.01%
+13,200
New +$134K